ABCG2 and neoplasm: Furthermore, knockdown of ABC transporters was found to suppress cholesterol efflux, revert the tumor-promoting functions of M2 macrophages, and inhibit tumor progression, highlighting the impact of metabolic alterations in resistance to CAR-T cell therapy26.